Pericardial Mesothelioma

Pericardial mesothelioma is the rarest form of mesothelioma, accounting for fewer than 1% of all cases. It develops in the pericardium — the thin, two-layered sac that surrounds the heart and the roots of the great vessels.¹

The pericardium consists of an outer fibrous layer and an inner serous layer (which itself has parietal and visceral components). Between these layers, a small amount of pericardial fluid (15–50 mL) reduces friction during cardiac contraction. When mesothelioma develops in this space, tumor growth and fluid accumulation can compress the heart and impair its function.²

Fewer than 200 cases of pericardial mesothelioma have been reported in the medical literature. The disease presents a significant diagnostic challenge: its symptoms mimic common cardiac conditions, the pericardium is difficult to biopsy safely, and in approximately 50% of documented cases, the diagnosis was not established until autopsy.³

The relationship between asbestos exposure and pericardial mesothelioma is less clearly established than for pleural or peritoneal types, largely because the rarity of the disease limits epidemiological study. However, asbestos exposure is identified in the history of roughly 25–50% of reported cases. The mechanism by which asbestos fibers reach the pericardium is not fully understood but may involve lymphatic or hematogenous (blood-borne) transport from the lungs.³

Pericardial mesothelioma symptoms are nonspecific and closely mimic those of other cardiac conditions, including pericarditis, cardiomyopathy, and congestive heart failure. This overlap contributes to the high rate of misdiagnosis and delayed detection.³

Common symptoms include:

• Chest pain — Substernal or precordial pain that may worsen with breathing, coughing, or changes in position (particularly lying down). The pain pattern can mimic pericarditis or angina.²
• Dyspnea (shortness of breath) — Progressive breathlessness caused by pericardial effusion compressing the heart and reducing cardiac output. Orthopnea (difficulty breathing while lying flat) is common.³
• Pericardial effusion — Fluid accumulation between the pericardial layers. This is the most common presenting finding and can range from mild (asymptomatic) to massive (causing hemodynamic compromise).³
• Heart palpitations and arrhythmias — Irregular heartbeat caused by tumor invasion of the myocardium or conduction system.²
• Fatigue and weakness — From reduced cardiac output and the systemic effects of malignancy.
• Lower extremity edema — Swelling of the feet and ankles from impaired venous return caused by cardiac compression.

Acute presentations:

• Cardiac tamponade — A life-threatening emergency in which rapid pericardial fluid accumulation compresses the heart, preventing it from filling adequately. Presents with Beck's triad: hypotension, distended neck veins, and muffled heart sounds. Requires emergency pericardiocentesis.³
• Constrictive pericarditis — Tumor encasement of the heart restricts diastolic filling, producing signs of right heart failure (ascites, hepatomegaly, peripheral edema).³

Because these symptoms are commonly attributed to benign cardiac conditions, pericardial mesothelioma should be considered in any patient with recurrent or refractory pericardial effusion, especially if there is a history of asbestos exposure.²

The etiology of pericardial mesothelioma is less well characterized than that of pleural or peritoneal types, primarily because the disease is so rare that large-scale epidemiological studies are not feasible.³

Asbestos exposure is documented in approximately 25–50% of reported cases. However, many case reports do not include detailed occupational histories, so the true proportion attributable to asbestos may be higher.³

The mechanism by which asbestos fibers reach the pericardium is not definitively established. Proposed pathways include:

• Lymphatic transport — Asbestos fibers inhaled into the lungs and transported to the pleura may migrate to the pericardium through the extensive lymphatic network connecting these serous cavities.³
• Hematogenous (blood-borne) transport — Fibers that enter the bloodstream through the pulmonary capillaries could be deposited in the pericardium during cardiac circulation.³

In cases without a documented asbestos exposure history, other potential risk factors include prior radiation therapy to the mediastinum and, rarely, germline BAP1 mutations. However, a significant proportion of pericardial mesothelioma cases remain idiopathic (no identified cause).²

Due to the extreme rarity of pericardial mesothelioma, risk factor data are limited to case reports and small case series:³

• Asbestos exposure — Identified in 25–50% of reported cases. Occupational exposure in construction, shipbuilding, and industrial settings is the most common association.³
• Age — Most cases are diagnosed in patients between 50 and 70 years of age, though cases have been reported across a wide age range.³
• Sex — Males are affected approximately twice as often as females in reported cases, consistent with higher occupational asbestos exposure in men.²
• Prior mediastinal radiation — Radiation therapy to the chest for treatment of lymphoma or other cancers has been reported as a potential risk factor in individual cases.²

Diagnosing pericardial mesothelioma is exceptionally challenging. The disease's rarity means that it is seldom considered in the differential diagnosis, and the pericardium's anatomic location limits safe biopsy access.³

Imaging

• Echocardiography — Often the first imaging study performed when cardiac symptoms are investigated. Echocardiography can detect pericardial effusion, pericardial thickening, and pericardial masses. However, it cannot distinguish mesothelioma from other pericardial tumors or inflammatory conditions.³
• CT scan — Contrast-enhanced CT of the chest shows pericardial thickening, nodularity, effusion, and potential invasion of adjacent structures (myocardium, great vessels, lungs). CT is essential for assessing disease extent.³
• Cardiac MRI — Provides superior soft-tissue contrast and is the best imaging modality for evaluating myocardial invasion and differentiating tumor from effusion or thrombus.³
• PET-CT — Identifies metabolically active disease and detects extrapericardial spread.²

Tissue sampling

• Pericardiocentesis — Drainage of pericardial fluid provides symptomatic relief (especially in tamponade) and fluid for cytological analysis. However, pericardial fluid cytology has low sensitivity for mesothelioma (approximately 20–30%), and a negative result does not exclude the diagnosis.³
• Pericardial biopsy — Surgical pericardial biopsy (via subxiphoid approach, thoracotomy, or pericardioscopy) provides tissue for histological diagnosis. This is the only reliable method for definitive diagnosis, but it carries procedural risks related to the proximity of the heart and great vessels.³

Histopathological confirmation uses the same immunohistochemistry markers as other mesothelioma types (calretinin, WT1, CK5/6 positive). It is essential to distinguish primary pericardial mesothelioma from metastatic tumors to the pericardium (more common than primary pericardial malignancies) and from pleural mesothelioma that has invaded the pericardium secondarily.³

Treatment options for pericardial mesothelioma are limited by the disease's rarity, late-stage diagnosis, and anatomic constraints. No standardized treatment protocol exists; management is individualized based on disease extent, symptoms, and patient fitness.³

Surgical options

• Pericardiectomy — Surgical removal of the pericardium (partial or total) is the only potentially curative treatment. Complete resection is rarely feasible due to tumor invasion of the myocardium, great vessels, or surrounding structures. When achievable, pericardiectomy combined with adjuvant therapy offers the best survival outcomes.³
• Pericardial window — Creation of an opening between the pericardium and pleural space (or peritoneal space) allows continuous drainage of pericardial fluid. This palliative procedure prevents recurrent tamponade.³
• Pericardiocentesis — Needle drainage of pericardial effusion for acute symptom relief. Often needs to be repeated as fluid reaccumulates.³

Systemic therapy

• Chemotherapy — Pemetrexed plus cisplatin or carboplatin is used based on extrapolation from pleural mesothelioma data. Response rates in pericardial mesothelioma are not well characterized due to the small number of treated cases.¹
• Immunotherapy — Nivolumab plus ipilimumab may be considered based on the CheckMate 743 results, though there are no pericardial mesothelioma-specific efficacy data.⁴

Radiation therapy

External beam radiation to the pericardium is technically challenging due to the risk of radiation-induced cardiac damage (radiation pericarditis, myocarditis, coronary artery disease). It is used selectively for palliation or as adjuvant therapy after pericardiectomy, with careful cardiac-sparing techniques.³

Palliative care

Given the poor overall prognosis, palliative care plays a central role in managing pericardial mesothelioma. Symptom management focuses on controlling dyspnea, chest pain, fluid accumulation, and arrhythmias. Early referral to palliative care services improves quality of life.²

Pericardial mesothelioma has the poorest prognosis of all mesothelioma types. The overall median survival from diagnosis is approximately 6 months, with most patients surviving fewer than 12 months.³

Factors affecting prognosis:

• Resectability — The small number of patients who undergo successful pericardiectomy with clear or near-clear margins have the best reported outcomes, with occasional survival exceeding 2 years.³
• Stage at diagnosis — Because pericardial mesothelioma is most commonly diagnosed at an advanced stage (or postmortem), treatment opportunities are limited. Incidental discovery at an earlier stage during cardiac surgery for other reasons has produced better outcomes in individual cases.³
• Cell type — As with other mesothelioma types, epithelioid histology carries a better prognosis than sarcomatoid or biphasic.²

The diagnosis of approximately 50% of pericardial mesothelioma cases at autopsy underscores the urgent need for improved ante-mortem diagnostic approaches and greater clinical awareness of this rare disease.³

Prevention of pericardial mesothelioma follows the same general principles as prevention of other asbestos-related diseases, though the association with asbestos is less clearly established for this type:²

• Asbestos avoidance — Minimizing exposure to asbestos in occupational and environmental settings through compliance with OSHA regulations, professional abatement, and respiratory protection.
• Exposure documentation — Workers and veterans with asbestos exposure histories should inform their healthcare providers, which helps ensure that unexplained cardiac symptoms are evaluated with mesothelioma as a differential diagnosis.
• Workplace decontamination — Preventing secondary exposure by following proper hygiene protocols (showering at the worksite, not bringing work clothes home).

No specific screening protocol exists for pericardial mesothelioma. Routine echocardiography is not recommended for asbestos-exposed individuals in the absence of cardiac symptoms.³

A pericardial mesothelioma diagnosis is extremely challenging for patients and families due to the disease's rarity, limited treatment options, and guarded prognosis.

• Specialized cardio-oncology care — Because the disease affects the heart, patients benefit from care by a multidisciplinary team that includes thoracic oncologists, cardiac surgeons, and cardiologists experienced in managing cardiac malignancies.
• Symptom management — Managing pericardial effusion, shortness of breath, chest pain, and fatigue is the primary focus of care. Procedures to drain fluid and medications to control heart rhythm and fluid balance can improve comfort significantly.
• Palliative care — Early referral to palliative care services is strongly recommended. Palliative care addresses physical symptoms, emotional distress, and practical needs, and is appropriate alongside active treatment.
• Second opinions — Given the rarity of the disease, patients should seek evaluation at a major cancer center with experience in rare thoracic malignancies.
• Legal and financial rights — Patients with asbestos-related pericardial mesothelioma have the same legal rights to compensation as those with pleural or peritoneal disease. Consult a mesothelioma attorney to understand available options.